Status:
COMPLETED
Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal)
Lead Sponsor:
Washington University School of Medicine
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
CareSignal has developed an application that allows for remote collection of patient-reported data such as symptoms or outcomes on any device compatible with the short message service (SMS), otherwise...
Eligibility Criteria
Inclusion
- Currently planning to receive radiotherapy for 2 or more fractions with or without chemotherapy.
- Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
- Age 18 years or older.
Exclusion
- Unable to reliably access and use a device compatible with CareSignal software.
Key Trial Info
Start Date :
September 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 9 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04437472
Start Date
September 22 2020
End Date
July 9 2021
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110